We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Times has reported that AstraZeneca’s new global headquarters in Cambridge has “more than doubled to £750 million, making it one of the most expensive corporate buildings in Britain.”